Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma

Advanced cutaneous squamous cell carcinoma (cSCC) encompasses unresectable and metastatic disease. Although immune checkpoint inhibition has been approved for this entity recently, a considerable proportion of cases is associated with significant morbidity and mortality. Clinical, histopathological,...

Descripción completa

Detalles Bibliográficos
Autores principales: Geidel, Glenn, Heidrich, Isabel, Kött, Julian, Schneider, Stefan W., Pantel, Klaus, Gebhardt, Christoffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943023/
https://www.ncbi.nlm.nih.gov/pubmed/35322182
http://dx.doi.org/10.1038/s41698-022-00261-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943023/
https://www.ncbi.nlm.nih.gov/pubmed/35322182
http://dx.doi.org/10.1038/s41698-022-00261-z

Ejemplares similares